Naoka Murakami
, Professor of Pediatrics and Internal Medicine, University of Iowa, Iowa City, IA · Washington University/B-JH/SLCH Consortium
Credentials: · · · · · · ·
History
- 2012–2015
- 2009–2012
- 2006–2010
Research
Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study
Journal of the American Society of Nephrology · 2020 · 303 citations
G2A is a proton-sensing G-protein-coupled receptor antagonized by lysophosphatidylcholine
Journal of Biological Chemistry · 2004 · First of 4 authors · 199 citations
Acute kidney injury in patients treated with immune checkpoint inhibitors
Journal for ImmunoTherapy of Cancer · 2021 · 189 citations
29 papers
12 papers
- JA
11 papers
- KJ
10 papers
9 papers
- DL
9 papers
8 papers · 3 as a fellow
8 papers
Grants
- 2024–2029
Antigen-Specific T Cells in Immunotherapy-Associated Acute Kidney Injury
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $963.7K · Washington University
- 2022–2024
National Institute of Diabetes and Digestive and Kidney Diseases · R03
Contact PI · $268.5K · Brigham and Women's Hospital
- 2019–2024
Protection of Kidney from Autoimmunity by Modulating Co-Stimlatory Signaling
National Institute of Diabetes and Digestive and Kidney Diseases · K08
Contact PI · $885.7K · Brigham and Women's Hospital
Clinical trials
- 2026–2031
Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma
Principal investigator · Not yet recruiting · Phase 2
Washington University School of Medicine